Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
주식 순위 #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
주가
$1.51
마지막 동기화: 2024-08-26
시가총액
$1.12M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Agile Therapeutics, Inc. (AGRX)

카테고리

Agile Therapeutics, Inc. (AGRX)의 주식 분할 이력
Agile Therapeutics, Inc. 주식 (심볼: AGRX)은 총 2회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Apr 11, 2023에 발생했습니다.
Apr 27, 2022 이전에 매수한 AGRX 주식 1주는 현재 0.0005주의 AGRX 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
2023-04-11 1:50 x0.02 x0.0005
2022-04-27 1:40 x0.025 x0.025
유사 기업 또는 경쟁사의 주식 분할